在LRRK2帕金森病中条状DAT结合的纵向下降:与CSFα-synuclein播种活动的联系
Jing Wang1,2, Xixi Sun3, Yunfei Yin3
1Division of Life Sciences and Medicine, Department of Urologic Oncology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230031, China.
Journal of neurology
|September 13, 2025
概括
帕金森病 (PD) 患者具有LRRK2突变和负的α-synuclein种子放大试验 (SAA) 显示较慢的多巴胺基损失. 脑液α-同核素SAA状态是LRRK2 PD诊断和预后的一个有用的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 生物标志物发现发现
背景情况:
- 与LRRK2突变相关的帕金森病 (PD) 呈现出病理变异性.
- 在脑脊液 (CSF) 中的α-synuclein种子放大试验 (SAA) 可以在体内可靠地检测α-synuclein聚合.
- 在LRRK2 PD中通过CSFα-synucleinSAA状态分层的纵向条状多巴胺成像的研究至关重要.
研究的目的:
- 为了研究LRRK2PD患者的条状多巴胺成像的纵向变化.
- 根据CSFα-synuclein SAA状态对LRRK2 PD患者进行分层.
- 评估SAA状态和随时间推移的多巴胺变性退化之间的关系.
主要方法:
- 利用了来自帕金森病进展标记计划 (PPMI) 的数据.
- 使用SAA进行评估的CSFα-synuclein聚合.
- 使用[123I]FP-CIT SPECT在基线,第二年和第四年量化带状多巴胺载体 (DAT) 特定结合比率 (SBR).
主要成果:
- 在基线时,α-synucleinSAA阴性LRRK2PD患者的DAT结合比SAA阳性患者高.
- 从长度来看,SAA阴性LRRK2PD患者随着时间的推移保持了显著更高的DAT结合.
- 在SAA阴性组的逆边尾状体中观察到较慢的DAT损失率.
结论:
- 条纹性多巴胺基退行变化的差异可能表明LRRK2 PD的区域特异性脆弱性.
- 脑液α-同核素SAA状态在LRRK2 PD中作为一种有价值的诊断和预后生物标志物.
- 这些发现支持α-synuclein SAA在治疗LRRK2-相关帕金森病的临床实用性.
更多相关视频
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
11.1K
06:09Semi-Quantitative Determination of Dopaminergic Neuron Density in the Substantia Nigra of Rodent Models using Automated Image Analysis
Published on: February 2, 2021
5.0K
相关概念视频
Neural Regulation
43.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.0K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
